Showing 1 - 10 results of 10 for search 'D.P. Devanand', query time: 0.25s
Refine Results
-
1
-
2
-
3
Olfaction and neurocognition after COVID-19: a scoping review by Brandon J. Vilarello, Patricia T. Jacobson, Jeremy P. Tervo, Nicholas A. Waring, David A. Gudis, David A. Gudis, Terry E. Goldberg, D. P. Devanand, D. P. Devanand, Jonathan B. Overdevest, Jonathan B. Overdevest
Published 2023-06-01
Article -
4
Models of depressive pseudoamnestic disorder by Jongwoo Choi, Seonjoo Lee, Jeffrey N. Motter, Hyun Kim, Howard Andrews, P. Murali Doraiswamy, D. P. Devanand, Terry E. Goldberg
Published 2022-01-01
Article -
5
The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode by Harold A. Sackeim, Joan Prudic, D.P. Devanand, Mitchell S. Nobler, Roger F. Haskett, Benoit H. Mulsant, Peter B. Rosenquist, William V. McCall
Published 2020-09-01
Article -
6
Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment by Daniel C. Javitt, Antigona Martinez, Pejman Sehatpour, Anna Beloborodova, Christian Habeck, Yunglin Gazes, Dalton Bermudez, Qolamreza R. Razlighi, D. P. Devanand, Yaakov Stern
Published 2023-02-01
Article -
7
Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population. by Yian Gu, Qolamreza R Razlighi, Laura B Zahodne, Sarah C Janicki, Masanori Ichise, Jennifer J Manly, D P Devanand, Adam M Brickman, Nicole Schupf, Richard Mayeux, Yaakov Stern
Published 2015-01-01
Article -
8
Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial by Howard Andrews, D P Devanand, William C Kreisl, Qolamreza Razlighi, Anne Gershon, Yaakov Stern, Akiva Mintz, Thomas Wisniewski, Edward Acosta, Julianna Pollina, Mariasofia Katsikoumbas, Karen L Bell, Gregory H Pelton, Deborah Deliyannides, K M Prasad
Published 2020-02-01
Article -
9
Recovery rates of persistent post‐COVID‐19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study by Jeremy P. Tervo, Patricia T. Jacobson, Brandon J. Vilarello, Tiana M. Saak, Francesco F. Caruana, Liam W. Gallagher, Joseph B. Gary, David A. Gudis, Paule V. Joseph, D.P. Devanand, Terry E. Goldberg, Jonathan B. Overdevest
Published 2024-06-01
Article -
10
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. by Lea T Drye, David Spragg, D P Devanand, Constantine Frangakis, Christopher Marano, Curtis L Meinert, Jacobo E Mintzer, Cynthia A Munro, Gregory Pelton, Bruce G Pollock, Anton P Porsteinsson, Peter V Rabins, Paul B Rosenberg, Lon S Schneider, David M Shade, Daniel Weintraub, Jerome Yesavage, Constantine G Lyketsos, CitAD Research Group
Published 2014-01-01
Article